Hemogenyx Pharmaceuticals Plc (LON:HEMO)
London · Delayed Price · Currency is GBP · Price in GBX 614.00
-96.00 (-13.52%)
Oct 15, 2026, 4:45 PM GMT
Hemogenyx Pharmaceuticals Market Cap
Hemogenyx Pharmaceuticals has a market cap or net worth of 41.75 million as of October 15, 2026. It is the 28,503rd most valuable company in the world and the 632nd biggest in the United Kingdom. Its market cap has decreased by 22.89% in one year.
Market Cap
41.75M
Enterprise Value
38.97M
Revenue
n/a
Global Rank
Country Rank
#632 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since October 6, 2017, Hemogenyx Pharmaceuticals's market cap has increased from 10.68M to 41.75M, an increase of 290.89%. That is a compound annual growth rate of 16.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 41.75M | 20.82% |
| Dec 31, 2025 | 34.56M | 143.47% |
| Dec 31, 2024 | 14.19M | -47.51% |
| Dec 29, 2023 | 27.04M | 108.28% |
| Dec 30, 2022 | 12.98M | -29.33% |
| Dec 31, 2021 | 18.37M | -56.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 6, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Scancell Holdings | 113.19M |
| Bioventix | 89.76M |
| 4basebio | 84.42M |
| Faron Pharmaceuticals Oy | 72.43M |
| Ondine Biomedical | 50.66M |
| Poolbeg Pharma | 48.40M |
| Sareum Holdings | 38.11M |
| Arecor Therapeutics | 37.71M |